About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Indy Hematology Review
http://www.indyhematologyreview.com/
2024
2023
2022
2021
Indy Hematology Review 2019 Conference
Indy Hematology Review 2018 Conference
MPN
Myeloma
Leukemia
Benign Hematology
Lymphoma
Challenging Case Presentations
Blood Disorders
Indy Hematology Review 2018
Nursing and Allied Providers Symposium Agenda 2018
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Indy Hematology Review 2023: Expert Case Discussions
By
Indy Hematology Review
FEATURING
Michael Wiemann
,
Saad Usmani
,
Joseph Mikhael
,
Matthew Lunning
,
Steven Treon
,
Tycel Phillips
,
Jennifer Woyach
By
Indy Hematology Review
FEATURING
Michael Wiemann
,
Saad Usmani
,
Joseph Mikhael
,
Matthew Lunning
,
Steven Treon
,
Tycel Phillips
,
Jennifer Woyach
65 views
April 20, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
2023
19:34
Indy Hematology Review
2023 Management of Long-Term Survivors of Hematologic Malignancies
Feat.
S. Garofalo
26:05
Indy Hematology Review
Understanding and Managing Immune Effector Cell Toxicities in Hemato…
Feat.
D. Reeves
73:56
Indy Hematology Review
Indy Hematology Review 2023: Expert Case Discussions
Feat.
M. Wiemann,
S. Usmani,
J. Mikhael,
M. Lunning,
S. Treon,
T. Phillips,
J. Woyach
21:29
Indy Hematology Review
Indy Hematology Review 2023: Emerging Therapies in Hematologic Malig…
Feat.
R. Birhiray
24:53
Indy Hematology Review
Emerging and Current Treatment of Amyloidosis and Waldenstrom’s Macr…
Feat.
M. Gertz
26:02
Indy Hematology Review
Recognizing Toxicities of Oral Oncolytics in the Management of Hemat…
Feat.
K. Orbaugh
31:33
Indy Hematology Review
Sickle Cell Disease and Clotting Disorders of the Blood in 2023
Feat.
C. Kessler
31:51
Indy Hematology Review
Managing Newly Diagnosed MM in 2023
Feat.
S. Usmani
22:30
Indy Hematology Review
Targets and Treatments of MPNs in 2023
Feat.
R. Mesa
32:06
Indy Hematology Review
Current and Emerging Therapies for AML and MDS
Feat.
R. Larson
24:33
Indy Hematology Review
Therapeutic Options in CLL in 2023: Choosing the Initial Therapy Wis…
Feat.
J. Woyach
31:25
Indy Hematology Review
Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…
Feat.
M. Lunning
34:28
Indy Hematology Review
Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas
Feat.
T. Phillips
19:42
Indy Hematology Review
Beyond Hyperviscosity: 80 Years and Counting - Treatment of Waldenst…
Feat.
S. Treon
18:27
Indy Hematology Review
DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…
Feat.
J. Mikhael
15:53
Indy Hematology Review
DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remissi…
Feat.
S. Usmani
06:33
Indy Hematology Review
Indy Hematology Review 2023: Take Home Messages for MDS & AML
Feat.
R. Komrokji
06:36
Indy Hematology Review
Indy Hematology Review 2023: Recent Important Results for Adult ALL
Feat.
C. Schiffer
04:15
Indy Hematology Review
Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…
Feat.
M. Gertz
28:07
Indy Hematology Review
Controversies and Recommendations for the Treatment of ALL and Lymph…
Feat.
W. Stock
38:55
Indy Hematology Review
Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…
Feat.
G. Salles
24:21
Indy Hematology Review
Emerging Therapies for R/R CLL
Feat.
W. Wierda
31:43
Indy Hematology Review
Myelofibrosis: Chronic and Blast Phase - 2023 Algorithms for Risk St…
Feat.
A. Tefferi
24:37
Indy Hematology Review
Recent Updates on the Treatment of Polycythemia Vera
Feat.
A. Fleischman
16:23
Indy Hematology Review
Updates on the Treatment of Myelofibrosis and FGFR-Mutated Myeloid N…
Feat.
A. Fleischman
32:03
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What S…
Feat.
K. Anderson
31:16
Indy Hematology Review
Hematopoietic Stem Cell Transplantation: State of the Art in 2023
Feat.
R. Childs
28:25
Indy Hematology Review
Managing the Benign Hematology Consult: Treatment Recommendations fo…
Feat.
C. Kessler
28:41
Indy Hematology Review
Improving Outcomes With Current Therapies in AML and Acute Promyeloc…
Feat.
M. Tallman
27:52
Indy Hematology Review
The Oracle of Apollo in Indianapolis: Prognosis and Treatment in MDS
Feat.
R. Stone
27:16
Indy Hematology Review
Resistant or Recurrent CML and Prospective Discontinuation
Feat.
R. Larson